Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Price to Sales (P/S)
since 2005

Microsoft Excel

Calculation

Medtronic PLC, P/S, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Medtronic PLC Annual Report.


The Price to Sales (P/S) ratio exhibits a volatile long-term trajectory characterized by an initial contraction, a period of recovery and peaking, and a subsequent recent decline. While sales per share have demonstrated consistent long-term growth, the market valuation expressed through the share price has fluctuated significantly, leading to substantial shifts in the valuation multiple.

Initial Valuation Contraction (2005–2012)
A significant downward trend in the P/S ratio is observed during this period, falling from a peak of 6.30 in 2005 to a low of 2.36 by 2012. This compression occurred despite a steady increase in sales per share, which rose from 8.28 to 15.79. This indicates that the share price declined or failed to keep pace with revenue growth, suggesting a reduction in the market's valuation premium during these years.
Recovery and Valuation Peak (2013–2021)
The valuation multiple entered a recovery phase starting in 2013, with the P/S ratio climbing to 5.36 by 2015. After a period of relative stability between 3.92 and 4.36 from 2016 to 2020, a sharp peak occurred in 2021, where the ratio reached 5.57. This spike was driven primarily by a substantial increase in the share price to 124.93, which significantly outpaced the growth in sales per share for that specific period.
Recent Valuation Compression (2022–2026)
A consistent decline in the P/S ratio is evident from 2022 onward, moving from 3.72 down to a projected 2.79 by 2026. This trend is marked by a decrease in share price from 88.67 to 79.34, even as sales per share continued to grow from 23.85 to 28.41. This divergence indicates a systemic compression of the revenue multiple, as the market is assigning less value to each dollar of sales generated.
Correlation Between Revenue and Price
The data reveals a decoupling between operational performance and market valuation. Sales per share have grown nearly 3.5 times from 2005 to 2026. However, the P/S ratio suggests that the market's willingness to pay a premium for these sales has diminished over the long term, returning toward levels not seen since the 2009–2012 period.

AI Ask an analyst for more



Comparison to Competitors

Medtronic PLC, P/S, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).



Comparison to Sector (Health Care Equipment & Services)

Medtronic PLC, P/S, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).



Comparison to Industry (Health Care)

Medtronic PLC, P/S, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).